- Home
- Events
- Conferences and Workshops
- 2022
- User Meeting 2022
- User-Dedicated Microsymposia
- UDM2. Ligand and fragment screening: enabling technologies for pressing threats
UDM2. Ligand and fragment screening: enabling technologies for pressing threats
W E B I N A R
Scientific Organisers | UOC Organiser: A. Miele ESRF Organisers: |
Keynote Speakers | Janosch Hennig - EMBL Heidelberg, Germany Ho-Leung Ng - Kansas State University, USA Ailsa Powell - Diamond Light Source, UK |
Administrative Assistant | Claudine Roméro |
Contact | udm2-um22@esrf.fr |
Format | Webinar |
Recordings of talks |
Aim & Scope
Modern drug development relies heavily on knowledge of the atomic structure of macromolecules and their complexes with small molecule drugs. This approach, called “Structure Based Drug Design” (SBDD) is central to the drug design process and relies heavily on structure determination methods such as cryoEM, NMR, SAXS and X-ray crystallography. With the EBS, the latter two methods have undergone significant upgrades in their capabilities at the ESRF. This UDM is dedicated to both experimental and analysis methodology as well as case studies of protein-ligand interactions, particularly in their application to drug development.